Market Updates

ArthroColl Study Begins

ArthroColl™ Study Begins
SPI Diana, Irvine, CA, has begun a nine-month, double blind, crossover clinical study on ArthroColl™ chicken collagen type II. The study, de­signed to illustrate the effects of ArthroColl on joint health, is currently underway in France, with results expected early next year.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters